Blonder Tongue Laboratories

Blonder Tongue Laboratories, Inc. operates as a technology development and manufacturing company, which engages in delivering television signal encoding, transcoding, digital transport, and broadband product solutions for applications. It also offers system operators and integrators serving the cable, broadcast, satellite, institutional, and professional video markets with solutions for the provision of content contribution, distribution, and video delivery to homes and businesses. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Blonder Tongue Laboratories, Inc. is a technology research and development company, which engages in designing and manufacturing cable television and video transmission technology. It also offers its products and services to major telecommunications, cable and fiber optic service delivery operators, as well as broadcasters, and media production companies. The company was founded by Ben H. Tongue and Isaac S. Blonder in 1950 and is headquartered in Old Bridge, NJ.

OLD BRIDGE, NJ / ACCESSWIRE / August 2, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today it will report its Second Quarter 2021 Earnings Results on Thursday, August 12, 2021, prior to market opening. Management will then host a teleconference to discuss the results with the investment community.

Blonder Tongue Schedules Conference Call to Discuss Second Quarter 2021 Earnings Results

OLD BRIDGE, NJ / ACCESSWIRE / July 6, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today that it has received forgiveness of $1,768,762 of loan proceeds ("PPP Loan") previously received under the Paycheck Protection Program ("PPP"). As previously disclosed, on April 10, 2020, the Company received a PPP Loan of $1,768,762 under the federal PPP Program.

Blonder Tongue Announces Forgiveness of CARES Act PPP Loan

NXG Platform with IP Multicast and OTT Unicast Significantly Reduces Operating Cost, Space and Time when SMB's Upgrade their IP Video Offerings OLD BRIDGE, NJ / ACCESSWIRE / June 16, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR), a leading US-based designer and manufacturer of telecommunications, video and cable transmission technologies, has partnered with Innovative Systems to launch two new solutions for Blonder Tongue's NXG IP Digital Video Signal Processing Platform. "Innovative Systems is well known for their high reliability systems and their pragmatic and cost effective approach to delivering IP video as well as their advanced middleware platform with user-friendly remote provisioning and solutions to support their Multi-Generation TV product," said Ted Grauch, President and CEO of Blonder Tongue Laboratories, "With new security, cryptographic features, and integration work just completed, our NXG Platform can now be deployed to provide a full range of on-property video services in QAM, Analog, IP Multicast or IP Unicast formats; all from a single Innovative Systems' IP Multicast feed.

Blonder Tongue Labs and Innovative Systems Enable Current and Legacy SMB and Hospitality Video Systems for IP Multicasting

OLD BRIDGE, NJ / ACCESSWIRE / May 13, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the first quarter ended March 31, 2021. Blonder Tongue Laboratories, Inc. net sales decreased $799,000 or 19.7% to $3,251,000 for the first quarter of 2021 from $4,050,000 for the comparable period in 2020.

Blonder Tongue Announces First Quarter 2021 Results

OLD BRIDGE, NJ / ACCESSWIRE / May 4, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today it will report its First Quarter 2021 Earnings Results on Thursday, May 13, 2021 prior to market opening. Management will then host a teleconference to discuss the results with the investment community.

Blonder Tongue Schedules Conference Call to Discuss First Quarter 2021 Earnings Results

OLD BRIDGE, NJ / ACCESSWIRE / April 7, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today that it has received notice from NYSE American LLC ("NYSE American") that it is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide"). That section applies if a listed company has stockholders' equity of less than $2 million and the listed company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years.

Blonder Tongue Announces Receipt of Noncompliance Notice from NYSE American

OLD BRIDGE, NJ / ACCESSWIRE / March 12, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced its sales and results for the fourth quarter and year ended December 31, 2020. Commenting on the year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, "Faced with a very difficult pandemic affected marketplace in 2020, the Company focused the year on completing a number of major organizational changes, R&D and intellectual property (IP) investments, product development, and inventory reduction programs.

Blonder Tongue Reports Fourth Quarter and Year End 2020 Results

OLD BRIDGE, NJ / ACCESSWIRE / March 4, 2021 / Blonder Tongue Laboratories, Inc. (NYSE American:BDR) announced today it will report its Fourth Quarter and Year End 2020 Earnings Results on Friday, March 12, 2021 prior to market opening. Management will then host a teleconference to discuss the results with the investment community.

Blonder Tongue Schedules Conference Call to Discuss Fourth Quarter and Year End 2020 Earnings Results

Bit Digital, Inc

EnLink Midstream

Smith & Wesson Brands

With the market at incredibly frothy valuations, buying into speculative ventures isn't for everyone. Still, if you can handle the potential volatility, these risky stocks to buy may have more room to run.

8 Risky Stocks to Buy If Danger Is Your Middle Name

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don't always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let's take a look at the recent hedge fund activity surrounding Blonder Tongue Labs, Inc. (NYSE:BDR).

Where Do Hedge Funds Stand On Blonder Tongue Labs, Inc. (BDR)?

Blonder Tongue Laboratories' (BDR) CEO Ted Grauch on Q2 2020 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) CEO Edward Grauch on Q1 2020 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) CEO Robert Pallé on Q3 2019 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) CEO Bob Pallé on Q2 2019 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) CEO Bob Palle on Q1 2019 Results - Earnings Call Transcript

Blonder Tongue Laboratories, Inc. (BDR) CEO Robert Palle on Q4 2018 Results - Earnings Call Transcript

News for Blonder Tongue Laboratories Stock (BDR)